Anebulo Pharmaceuticals, Inc. (ANEB )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol ANEB
- Company Anebulo Pharmaceuticals, Inc.
- Price $0.55
- Changes Percentage 47.57
- Change 0.1773
- Day Low $0.38
- Day High $0.55
- Year High $3.42
- Year Low $0.3
- Market Cap $18,353,129
- Price Avg 50 EMA (D) $0.8
- Price Avg 200 EMA (D) $1.83
- Exchange NASDAQ
- Volume 2,778
- Average Volume 114,800
- Open $0.38
- Previous Close $0.37
- EPS -0.18
- PE -2.50
- Earnings Announcement 2026-05-07 12:00:00
- Shares Outstanding $40,784,731
Company brief: ANEBULO PHARMACEUTICALS, INC. (ANEB )
- Healthcare
- Biotechnology
- Mr. Richard Anthony Cunningham
- https://www.anebulo.com
- US
- N/A
- 05-07-2021
- US0345691036
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.